Dr. Javier Cepeda
Javier A. Cepeda, PhD, MPH is Assistant Professor in the Division of Global Public Health within the Department of Medicine at UCSD. He was trained in epidemiology of microbial diseases at Yale University where he received his MPH and PhD. He conducted his postdoctoral research in infectious diseases in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and a second postdoctoral fellowship at UCSD where he obtained training in economic evaluations of HIV prevention interventions.
He has 10 years’ experience investigating the intersecting epidemics of HIV and hepatitis C virus, substance use, and incarceration and has been involved in projects based in the United States, India, Mexico, and Russia. His current research involves assessing the impact of a police education program (Proyecto Escudo) in Tijuana, Mexico on HIV incidence among people who inject drugs. His Mentored Research Scientist Development Award will also examine the cost-effectiveness of implementing such interventions in order to inform evidence-based policymaking in resource limited settings. Dr. Cepeda is also interested in developing novel interventions to align law enforcement with public health in environments where injection drug use and HIV are highly stigmatized. He intends to use findings from his current research to inform future interventions to increase HIV testing and linkage to care.
Cepeda JA, Solomon SS, Srikrishnan AK, McFall AM, Kumar MS, Vasudevan CK, Anand S, Celentano DD, Lucas GM, Mehta SH. Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression. J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001372.
Cepeda JA, Thomas DL, Astemborski J, Sulkowski MS, Kirk GD, Mehta SH. Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study. Clin Infect Dis. 2017 Mar 10. doi: 10.1093/cid/cix207.
Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014 May;174(5):721-9. doi: 10.1001/jamainternmed.2014.601. PubMed PMID: 24687044; PubMed Central PMCID: PMC4074594.
Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. Lancet HIV. 2014 Nov 1;1(2):e77-e84. PubMed PMID: 25473651; PubMed Central PMCID: PMC4249702.
Cepeda JA, Niccolai LM, Lyubimova A, Kershaw T, Levina O, Heimer R. High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia. Drug Alcohol Depend. 2015 Feb 1;147:196-202. doi: 10.1016/j.drugalcdep.2014.11.021. Epub 2014 Dec 2. PubMed PMID: 25496706; PubMed Central PMCID: PMC4297682.